TMCnet News
Follicular Lymphoma - Pipeline Review - Comparative Analysis, Therapeutics Assessment, Mechanism of Action & Route of Administration - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/xksdwh/follicular) has announced the addition of the "Follicular Lymphoma - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Follicular Lymphoma , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Lymphoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce firt-in-class and best-in-class products. Companies Mentioned:
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/xksdwh/follicular View source version on businesswire.com: http://www.businesswire.com/news/home/20160129005415/en/ |